Biochemical characterization uncovers promising antimicrobial properties in bacillus isolates, suggesting alternatives to combat multi-drug resistant infections.
Background: There is an increasing need for the exploration of alternative sources of antimicrobial agents as a result of the increasing prevalence of multi-drug resistant (MDR) pathogens. Bacillus species from diverse soil samples were isolated within Dutse, Jigawa State, Nigeria. Methods: Six different Bacillus isolates were identified based on cultural, morphological, and biochemical characteristics: P. polymyxa, B. subtilis, B. cereus, B. pumilus, B. megaterium, and B. licheniformis. Antibacterial activities of these isolates were assessed using agar well diffusion against clinically isolated pathogens: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Results: Results showed that B. licheniformis showed the broadest spectrum with zones of inhibition of (23.0 ± 0.8 mm) against S. aureus and (14.0 ± 0.6 mm) against P. aeruginosa. B. subtilis likewise displayed extremely potent inhibitory action against S. aureus (19.0 ± 1.0 mm) and P. aeruginosa (21.0 ± 0.7 mm). On the other hand, B. cereus and P. polymyxa displayed moderate activity while B. megaterium and B. pumilus showed little to no zone of inhibition against some of the pathogens. Conclusion: These findings highlight soil-borne Bacillus species as promising candidates for novel antimicrobial drug discovery with potential contributions to addressing the global challenge of antibiotic resistance.
No takes yet. Share an insight, caveat, or question.
Abbey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: